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NAD Biosynthesis: Identification of the
Tryptophan to Quinolinate Pathway in Bacteria
followed by the 3-hydroxyanthranilate-3,4-dioxygenase
(HAD)-catalyzed complex oxidative rearrangement of
3-hydroxyanthranilate yields quinolinate [9–11].
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While it is generally believed that the tryptophan to quin-
olinic acid biosynthetic pathway is unique to eukaryotes,
Summary labeling studies, using 14C-tryptophan, demonstrate that
Streptomyces antibioticus, Cyanidium caldarium, Kar-
Previous studies have demonstrated two different bio- lingia rosea, and Xanthomonas pruni can utilize trypto-
synthetic pathways to quinolinate, the universal de phan to biosynthesize quinolinic acid [20, 21]. In addi-
novo precursor to the pyridine ring of NAD. In prokary- tion, the biosynthesis of actinomycin by Streptomyces
otes, quinolinate is formed from aspartate and dihy- antibioticus involves the conversion of tryptophan to
droxyacetone phosphate; in eukaryotes, it is formed 3-hydroxyanthranilic acid, utilizing the first four of the
from tryptophan. It has been generally believed that five enzymes involved in quinolinic acid formation [22].
the tryptophan to quinolinic acid biosynthetic pathway Furthermore, tryptophan dioxygenase, kynureninase,
is unique to eukaryotes; however, this paper describes and anthranilate 1,2-dioxygenase activities have been
the use of comparative genome analysis to identify detected in Pseudomonas aureofaciens [23], N-formyl-
likely candidates for all five genes involved in the tryp- kynurenine formamidase has been purified from Strep-
tophan to quinolinic acid pathway in several bacteria. tomyces parvulus [24], and kynureninase has been puri-
Representative examples of each of these genes were fied from Pseudomonas fluorescens [9]. However, with
overexpressed, and the predicted functions are con- the exception of the kynureninase, which has been thor-
firmed in each case using unambiguous biochemical oughly characterized, none of the other bacterial genes
assays. have been identified, and very little mechanistic enzy-
mology has been reported on these important enzymes.
Introduction In addition to the biosynthesis of NAD, the tryptophan
to quinolinic acid biosynthetic pathway plays an impor-
Nicotinamide adenine dinucleotide (NAD) and its phos- tant role in several other biological processes [25]. For
phate (NADP) are essential redox cofactors in all living example, alterations in brain serotonin levels are known
systems. In addition to its redox role as a hydride ac- to result in mood disorders [26], and the availability of
ceptor, this cofactor is a substrate for protein ADP- tryptophan for serotonin synthesis in the brain appears
ribosylation, which occurs as a regulatory event in DNA to be dependent on the rate of hepatic tryptophan-2,3-
repair [1] and in the activation of cholera and diphtheria
dioxygenase activity [15]. It has also been recently dem-
toxins [2]. ADP-ribosylation also functions as part of the
onstrated that 3-hydroxykynurenine induces apoptosis
catalytic mechanism of NAD-dependent histone deacet-
of neurons prepared from rat striatum [27–31] and cross-
ylases [3].
linking reactions mediated by 3-hydroxykynurenine mayPrevious studies have demonstrated two different bio-
play a role in cataract formation in the mammalian eyesynthetic pathways to quinolinate, the universal de novo
[32–35]. 3-hydroxykynurenine and quinolinate concen-precursor to the pyridine ring of NAD [4, 5]. In prokary-
trations are elevated in patients with AIDS-related de-otes, quinolinate is formed from aspartate and dihy-
mentia, Huntington’s disease, and hepatic encephalop-droxyacetone phosphate; in eukaryotes, it is formed
athy. Furthermore, quinolinate acts on NMDA receptorsfrom tryptophan (Figure 1). In the eukaryotic pathway,
in the brain causing neuronal injury and death. Mecha-tryptophan is cleaved by tryptophan-2,3-dioxygenase
nistic and structural studies on the quinolinate pathway(TDO) to yield N-formylkynurenine [6]. Removal of the
biosynthetic enzymes will facilitate the identification offormyl group by N-formylkynurenine formamidase (KFA)
small molecule inhibitors to better understand and con-results in kynurenine [7]. Hydroxylation, catalyzed by
trol these disease states.kynurenine-3-monooxygenase (KMO) gives 3-hydroxy-
In this paper, we describe the use of comparativekynurenine [8]. Cleavage of the amino acid side chain
genome analysis to identify likely candidates for all fiveby kynureninase (KYN) to give 3-hydroxyanthranilate,
genes involved in the tryptophan to quinolinic acid path-
way in several bacteria. Representative examples of each
*Correspondence: tpb2@cornell.edu (T.P.B.), osterman@burnham.
of these genes are overexpressed, and unambiguousorg (A.O.)
biochemical assays were used to confirm the predicted3 Present Address: The Burnham Institute, 10901 North Torrey Pines
Road, La Jolla, California 92037. functions in each case.
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Figure 1. The Two Biosynthetic Routes to
Quinolinic Acid
Results and Discussion identified eukaryotic KFA [36]. These observations indi-
cate the possible existence of a nonorthologus form of
KFA, characteristic of Cytophaga and Xanthomonas ssp.Identification of the Tryptophan to Quinolinate
Biosynthetic Enzymes in Bacteria Potential Ralstonia metallidurans genes for TDO, KYN,
and HAD were readily identified using homology searchesWhile clear evidence from labeling studies exists for the
occurrence of the tryptophan to quinolinate pathway in of public sequence archives and the ERGO database.
The R. metallidurans KFA gene could not be identifiedbacteria, until recently the kynureninase (KYN) gene from
Pseudomonas fluorescens was the only characterized in the same way because a reference sequence had not
yet been determined. Instead, we made a functionalbacterial gene related to this pathway. By screening geno-
mic archives, we detected the presence of eukaryotic prediction for a potential KFA gene by using the genome
context analysis approach [37]. We identified a previouslytryptophan-2,3-dioxygenase (TDO), kynurenine-3-mono-
oxygenase (KMO), and 3-hydroxyanthranilate-3,4-dioxy- uncharacterized gene, possessing a metal-dependent
hydrolase sequence signature, as a putative bacterialgenase (HAD) homologs in a few recently sequenced bac-
terial genomes, including Cytophaga hutchinsonii and KFA-encoding gene due to its strong tendency to cluster
on the chromosome with the TDO and KYN genes. ThisRalstonia metallidurans. Identification of these genes
along with the discovery of bacterial kynureninase ho- functional prediction was experimentally verified by over-
expression and preliminary enzymatic characterizationmologs enabled us to identify a tryptophan to quinoli-
nate pathway in bacterial species. of the protein and is fully described by us elsewhere [38].
The predicted gene functions from R. metalliduransCytophaga hutchinsonii was the first bacterial ge-
nome available to us containing orthologs of both the and C. hutchinsonii were validated as part of the tryp-
tophan to quinolinate pathway by coexpressing theKMO and HAD enzymes encoded within an operon-like
genomic cluster with the KYN encoding gene (see Figure KYN-KFA-TDO gene cluster from R. metallidurans with
the HAD-KYN-KMO gene cluster from C. hutchinsonii in2). A putative ortholog of the TDO gene was also identi-
fied outside of the KMO-KYN-HAD cluster. In addition, an E. coli mutant incapable of biosynthesizing quinoli-
nate. Further confirmation of the predicted functionsthe presence of the nadC gene and the absence of the
nadB-nadA genes (see Table 1) provided strong evi- was accomplished by the biochemical characterization
of a gene product from either organism for each uniquedence for the prediction of a eukaryotic-like quinolinate
biosynthesis from L-tryptophan in this bacterium. An functional assignment.
While this work was in progress, the recently sequencedintriguing feature of C. hutchinsonii, as well as of the
recently sequenced Xanthomonas axonopodis and Xan- bacterial genomes Gemmata sp. and Polaribacter fila-
mentus became available. Since neither organism con-thomonas campestris genomes, is the absence of bac-
terial KFA homologs (see Table 1). Furthermore, these tains the genes required for de novo biosynthesis or
niacin salvage, the tryptophan to quinolinate pathwaygenomes do not contain any homologs of the recently
The Tryptophan to Quinolinate Pathway in Bacteria
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Figure 2. Chromosomal Clustering of Genes Involved with the L-Tryptophan to Quinolinate Pathway
Contigs of four microbial genomes are aligned (“pinned”) around orthologs of KMO gene (1). Relevant homologous genes conserved in this
genomic neighborhood are labeled with matching patterns and numbers: 2, KYN; 3, HAD; 4, KFA. Nonconserved genes are colored gray. The
presence of NAD kinase (5) in the same chromosomal neighborhood was detected only for Xanthomonas ssp.
is the only conceivable route for NAD biosynthesis. anthranilic acid. The observed growth of the doubly
transformed nadA mutant provided strong support forThese two genomes do in fact contain all five genes
required for biosynthesis of quinolinate from tryptophan. the putative functional assignments.
Remarkably, these genomes also revealed a character-
istic chromosomal clustering pattern. In P. filamentus, Overexpression and Characterization
the KMO, KYN, and HAD genes are clustered on the of Tryptophan-2,3-Dioxygenase
chromosome, and Gemmata sp. provides the first exam- The putative TDO gene from R. metallidurans was over-
ple of bacterial KFA coclustered with these genes (see expressed as a soluble 34 kDa protein and readily puri-
Figure 2). The presence of a complete tryptophan to fied by Ni-NTA affinity chromatography (Figure 3, lanes
quinolinate pathway in Gemmata sp. and P. filamentus 2 and 3). The enzyme is a tetramer in its active form.
is further validation of the functional assignments made The enzyme catalyzes the oxidation of tryptophan to
to the C. hutchinsonii and R. metallidurans genome se- N-formylkynurenine, and the identity of the reaction
quences. product was confirmed by HPLC and NMR analysis. The
enzyme was assayed by monitoring the appearance of
N-formylkynurenine at 321 nm. Kinetic parameters areVerification of the Tryptophan to Quinolinate
shown in Table 2. The enzyme demonstrated no activityPathway by In Vivo Complementation
increase with the addition of external heme to the reac-E. coli MG1655:(pnuC-nadA), which is unable to bio-
tion mixture, establishing that the cofactor was not lim-synthesize quinolinic acid, was cotransformed with plas-
iting.mids containing the R. metallidurans, KFA-TDO-KYN
The oxidative ring opening of aromatic compounds isputative operon [pPRO-rmLocus(RT)], and the C. hutch-
typically catalyzed by nonheme iron-dependent enzymes,insonii HAD-KYN-KMO putative operon (pBAD-chLocus)
and the use of the heme cofactor for the opening of theto verify the possibility of in vivo conversion of tryp-
indole ring is unusual. The mechanism of this reactiontophan to quinolinate. Stable cotransformants con-
is still poorly understood, and there is no structure avail-taining both plasmids grew normally in rich medium and
able for any member of this family.in minimal medium supplemented with niacin. In the
absence of niacin but in the presence of 100 M trypto-
phan, they grew slowly, requiring approximately 72 hr Overexpression and Characterization
of N-Formylkynurenine Formamidaseto reach an OD600 2 in liquid minimal medium and to
form colonies on minimal agar plates. Control strains The putative KFA gene from R. metallidurans contained
a stop codon in the middle of the coding region, andcotransformed by both “empty” vectors (pPROLar and
pBAD) or by one vector plasmid and one construct [either the corresponding truncated protein had no enzymatic
activity. This mutation was corrected, and the resultingpPRO-rmLocus(RT) or pBAD-chLocus] grew normally in
the minimal medium supplemented by niacin but did KFA gene was overexpressed as a soluble 23.3 kDa
protein and readily purified by Ni-NTA affinity chroma-not grow in the presence of tryptophan. No growth of
the E. coli MG1655:(pnuC-nadA) [pPRO-rmLocus(RT); tography (Figure 3, lanes 4 and 5). The product of the
enzymatic reaction was identified as kynurenine bypBAD-chLocus] was observed over 96 hr in the absence
of added tryptophan. This was unanticipated; while the HPLC and NMR analysis. The enzyme was assayed by
monitoring the disappearance of N-formylkynurenine atE. coli strain used is not a tryptophan auxotroph, appar-
ently the endogenous tryptophan concentrations are not 321 nm. Kinetic parameters are shown in Table 2 and
are corrected for the slow nonenzymatic hydrolysis ofsufficient to support quinolinate biosynthesis using the
installed tryptophan pathway, possibly because of the the substrate. The enzyme displays a sharp pH optimum
at pH 8.0 and is inhibited by EDTA but not PMSF. Incompeting nonproductive degradation of tryptophan to
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Overexpression and Characterization
of 3-Hydroxy-Kynureninase
The putative KYN gene from R. metallidurans was over-
expressed as a soluble 44.8 kDa protein and purified by
Ni-NTA affinity chromatography (Figure 3, lanes 8 and
9). The enzyme contains tightly bound pyridoxal phos-
phate as a cofactor. KYN catalyzes the cleavage of the
side chain from both 3-hydroxykynurenine and from kyn-
urenine to give 3-hydroxyanthranilic acid and anthranilic
acid, respectively. In each case, the products of the
enzymatic reaction were confirmed by HPLC and NMR
analysis. The enzyme was assayed by monitoring the
disappearance of L-3-hydroxykynurenine at 371 nm or
Figure 3. SDS PAGE Analysis of the Overexpression of the Enzymes L-kynurenine at 360 nm. Kinetic parameters are shown
Involved in the Conversion of Tryptophan to Quinolinic Acid in Table 2.
Lane 1: molecular weight standards. Lanes 2 and 3: TDO-soluble
cell-free extract and purified protein. Lanes 4 and 5: KFA-soluble Overexpression and Characterization
cell-free extract and purified protein. Lanes 6 and 7: KMO-soluble cell- of 3-Hydroxyanthranilate-3,4-Dioxygenasefree extract and purified protein. Lanes 8 and 9: KYN-soluble
The predicted HAD gene from R. metallidurans was over-cell-free extract and purified protein. Lanes 10 and 11: HAD-soluble
expressed as a soluble 22.5 kDa protein. While the en-cell-free extract and purified protein.
zyme was readily purified by Ni-NTA affinity chroma-
tography, the purified protein lost most of its catalytic
activity (Figure 3, lanes 10 and 11). Functional character-addition, a conserved metal binding site can be identi-
ization was therefore carried out using gel-filtered cell-fied in the sequence. This suggests that bacterial KFA
free extract from the overexpression strain. HAD requiresmay be a zinc ion-dependent metalloprotease and not
iron (II) as a cofactor. HPLC and NMR analysis of thea serine protease as has been found for the mammalian
enzymatic reaction mixture demonstrated the formationand the avian enzyme.
of -amino--carboxymuconic semialdehyde, which un-
derwent a nonenzymatic conversion to quinolinate. The
enzyme was assayed by monitoring the appearance of
Overexpression and Characterization
-amino--carboxymuconic semialdehyde at 360 nm.
of Kynurenine-3-Monooxygenase The reaction shows substrate inhibition (Ki, 1.35 mM),
The predicted KMO gene from C. hutchinsonii was over- and the kinetic parameters are shown in Table 2.
expressed as an insoluble 54 kDa protein. However, The mechanism of 3-hydroxyanthranilate-3,4-dioxy-
soluble preparations could be obtained by adding 0.2% genase is likely to be similar to the mechanism of the
Triton X-100 to the buffers used for cell lysis and enzyme well-studied catechol dioxygenases [39]. However, the
purification. Under these conditions, the enzyme was mechanism of its inhibition by such molecules as 4-chloro-
readily purified by Ni-NTA affinity chromatography (Fig- 3-hydroxyanthranilate, as well as the mechanism by which
ure 3, lanes 6 and 7). KMO contains a tightly bound -amino--carboxymuconic semialdehyde cyclizes to
flavin cofactor (FAD). The enzyme was assayed by moni- quinolinic acid, remain to be elucidated.
toring the disappearance of NADPH at 340 nm. Kinetic
parameters are shown in Table 2. The enzyme will also Significance
utilize NADH with a 50% reduction in Vmax.
Kynurenine-3-monooxygenase is a member of a well- Quinolinate is the precursor to NAD in both prokaryotic
studied enzyme family that utilizes a flavin hydroperox- and eukaryotic organisms. The biosynthesis of quinoli-
ide to hydroxylate electron-rich aromatic compounds. nate from tryptophan, previously identified only in
The availability of this enzyme in large quantities will eukaryotic organisms, is still poorly understood due
to the experimental intractability of the eukaryotic en-facilitate the design of inhibitors.
Table 2. Kinetic Parameters for the Enzymes of the Tryptophan to Quinolinate Pathway
Subunit kcat/
Enzyme Mass (kDa) Km (mM) kcat (s1) Km(M1s1) Cofactor
Tryptophan-2,3-dioxygenasea 34 0.35  0.3 22.6 6.4  104 heme/Fe
N-formylkynurenine formamidasea 23.3 0.075  0.009 0.77  0.03 1.03 104 ND
Kynurenine-3-monooxygenaseb 54 0.076  0.004 (Kyn) 2.15 2.8  104 FAD
0.089  0.006 (NADPH)
3-hydroxy-kynureninasea 44.8 0.07  0.06 (Kyn) 4.52 (Kyn) 6.4  104 PLP
0.040  0.002 (hydroxyKyn) 2.9 (hydroxyKyn) 7.4  104
3-hydroxyanthranilate-3,4-dioxygenasea 22.5 1.22  0.07 8.65 7.1  103 Fe
a From Ralstonia metallidurans.
b From Cytophaga hutchinsonii.
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For the determination of kinetic parameters, initial rates werezymes. In this study, comparative genome analysis
plotted versus the substrate concentration and fit to the Michaelisand metabolic reconstruction of the tryptophan to
Menten equation using Origin 6.0 [41]. For HAD, which shows sub-quinolinate pathway in several bacterial species was
strate inhibition, initial rates were plotted versus the substrate con-
performed using the ERGO genomic database and a centration and fit to 	 
 VmaxS/(SKm(S2/Ki)).
set of tools implemented therein. Implementation of
these techniques culminated with the discovery of the Identification of the Tryptophan to Quinolinate Pathway
in Bacteriatryptophan to quinolinate pathway in several bacterial
Comparative genome analysis and metabolic reconstruction ofspecies. The five bacterial enzymes required to con-
quinolinate/NAD biosynthesis in various species was performed us-vert tryptophan to quinolinate were cloned, overex-
ing the ERGO genomic database and a set of tools implementedpressed, and unambiguously characterized. The sta- therein [42]. The genes coding for the enzymes involved in the trypto-
bility of the bacterial proteins allows for mechanistic phan to quinolinate pathway in bacterial genomes were tentatively
and structural studies that are not possible with the identified by homology with known sequences from H. sapiens and
S. cerevisiae, except for bacterial KFA. The gene encoding for theeukaryotic enzymes, and the neurotoxicity of the path-
latter enzyme was identified and experimentally verified by us inway metabolites makes detailed study of their enzy-
representative gram-negative and gram-positive bacteria [38]. Or-matic formation of great interest. This study demon-
thologs of bacterial KFA are not present in eukaryotes but they arestrates the enormous potential within the extensive found by homology searches in a number of bacteria, including
bacterial genomic archives available for exploration. those containing other putative genes involved with the tryptophan
There are many examples of important enzymes, con- to quinolinate pathway. Additional public bioinformatics resources
used were GenBank (http://www.ncbi.nlm.nih.gov/Genbank/index.sidered unique to eukaryotic biosynthetic pathways,
html), PSI-BLAST (http://www.ncbi.nlm.nih.gov/BLAST/), and PFAMthat are experimentally intractable due to instability,
(http://pfam.wustl.edu/). Genomic sequences used in this studyinclusion body formation, or failure to overexpress. As
were E. coli K12 MG1655 (GenBank U00096), Pseudomonas aerugi-demonstrated here, the use of comparative genomics nosa PA01 (GenBank AE004091), Ralstonia solanacearum (GenBank
to identify bacterial orthologs for all of the five en- AL646052), Ralstonia metallidurans CH34 (formerly Ralstonia eutro-
zymes involved in the conversion of tryptophan to pha or Alcaligenes eutrophus; http://www.jgi.doe.gov/JGI_microbial/
html/ralstonia/ralston_homepage.html), Cytophaga hutchinsoniiquinolinate enabled us to overexpress each of these
ATCC 33406 (GenBank AE016877), Bacillus cereus ATCC 14579enzymes as soluble proteins, opening up this impor-
(GenBank AE016877), Bacillus subtilis subsp. subtilis str. 168 (Gen-tant “eukaryotic” biosynthetic pathway to mechanistic
Bank AL009126), Xanthomonas axonopodis pv. citri str. 306 (Gen-and structural studies. With the availability of more Bank AE008923), Saccharomyces cerevisiae (http://genome-www.
than 400 bacterial genome sequences, the search for stanford.edu/Saccharomyces/), Homo sapiens (http://www.ncbi.
bacterial orthologs of experimentally intractable eu- nlm.nih.gov/mapview/map_search.cgi?taxid
9606), and Araba-
dopsis thaliana (http://www.ncbi.nlm.nih.gov/mapview/map_search.karyotic proteins is likely to be a productive one.
cgi?taxid
3702). Polaribacter filamentus and Gemmata sp. ge-
nomes were sequenced and analyzed by Integrated Genomics. Se-Experimental Procedures
quences of the genes related to quinolinate/NAD biosynthesis re-
ferred to in this study are deposited in GenBank.Bacterial Strains, Media Components, Plasmids, Reagents,
and General Procedures
Cloning of the Quinolinate Biosynthetic Gene ClustersEscherichia coli strains DH5 (Life Technologies, Rockville, MD),
The KFA-KYN-TDO gene cluster from R. metallidurans CH34 wasTOP10, BL21(DE3), and Tuner(DE3) (Stratagene, La Jolla, CA) were
PCR amplified and cloned into a pPro-LAR vector, and the naturallyused for cloning and protein overexpression. E. coli K-12 strain
occurring stop codon disrupting the KFA encoding was correctedMG1655 was used for the complementation experiments. Chromo-
(TAA→TAC; Stop82Tyr) by site-directed mutagenesis [38]. The re-somal DNA from Cytophaga hutchinsonii ATCC 33406 was obtained
sultant plasmid pPRO-rmLocus(RT) was used by us in this studyfrom M.J. McBride (University of Wisconsin, Milwaukee). E. coli
for (a) in vivo quinolinate pathway verification and (b) amplification,strains were grown on LB media or M9 minimal media (Sigma) under
cloning, overexpression, purification, and in vitro characterization ofstandard laboratory conditions. A pProEX HTa vector (Life Technol-
R. metallidurans KFA* (with corrected stop codon), R. metalliduransogies) containing a Trc promoter, N-terminal His6tag, and TEV-prote-
KYN, and R. metallidurans TDO.ase cleavage site, or a pET16b vector (Novagen) containing a T7
The PCR amplification of the HAD-KYN-KMO gene cluster frompromoter, N-terminal His10tag, and a Factor Xa cleavage site were
C. hutchinsonii ATCC 33406 was achieved using 5-ATGCTCAAGCused for cloning and protein expression. Engineering of the expres-
CATTTAACTTCAAAGTCTG-3 and 5-TTATATATATTTTTTTGTCACsion plasmid pPRO-rmLocus(RT) containing a modified operon-like
TGTAATGACTTTATTTTTTAATTCTTCTG-3 as the forward and re-segment from R. metallidurans encoding KFA*-KYN-TDO in the
verse primers, respectively. The PCR-amplified fragment was puri-pPROLar.A122 vector (Clontech) under control of the IPTG-inducible
fied and directly cloned into pBAD-TOPO via the “TOPO TA” cloningPlac/ara1 hybrid promoter used in this study is described by us else-
strategy. E. coli strain TOP10 was used for subsequent transforma-where [38]. The vector pBAD-TOPO (Stratagene) with the L-arabi-
tion. The resultant plasmid pBAD-chLocus was verified by DNAnose-inducible araBAD promoter (PBAD) was used for cloning of the
sequence analysis.C. hutchinsonii ATCC 33406 operon-like locus encoding HAD-
KYN-KMO. Oligonucleotide primers were made by the Oligonucleo-
tide Synthesis Facility at the Cornell University Bioresource Center, Engineering the E. coli MG1655 pnuC-nadA Deletion Mutant
The E. coli nadA-pnuC operon was deleted using the PCR product-or were obtained from Sigma-Genosys (Woodlands, TX), or from
MWG Biotech Inc (High Point, NC). PCR reagents and enzymes for mediated one-step gene inactivation procedure as previously de-
scribed [43]. A pair of long composite primers each containing a 20DNA manipulations were from New England Biolabs (Beverly, MA)
and Fermentas (Vilnius, Lithuania). Plasmid purification kits and Ni- bp long priming sequence (shown below in lower case) and a 40
bp extension homologous to the region immediately upstream ofNTA resin were purchased from Qiagen (Valencia, CA). Reagents
for DNA sequencing were from PE Biosystems (Foster City, CA). the nadA or downstream of the pnuC coding sequence (upper case)
were designed as follows. Forward primer: 5-TGTCGGTTTTAACGAntibiotics, buffer components, and all reagents for enzymatic
assays and chemical synthesis were from Sigma-Aldrich. The basic TTAAGCCTGTAAAACGAGATGGTAAGgtgtaggctggagctgcttc-3; re-
verse primer: 5-ACCTGAATGAAGGGGTGTCTGGCCATTCACATCmolecular biology procedures for bacterial growth, plasmid prepara-
tion, restriction analysis, and transformation of competent cells were ATCACCAcatatgaatatcctccttagt-3. Using this set of primers and the
pKD3 plasmid [43] as a template, the chloramphenicol-resistanceperformed as described by Maniatis et al. [40].
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cassette flanked by regions of homology with the nadA-pnuC locus 1ml/min; solvent 9:1 0.1% aqueous trifluoroacetic acid:acetonitrile)
with detection of N-formylkynurenine by absorbance at 321 nm orwas amplified. The PCR product was gel purified and electroporated
into MG1655 cells expressing the lambda red recombination pro- the fluorescence of tryptophan at 366 nm (excitation at 286 nm).
N-formylkynurenine and tryptophan eluted after 5 and 8 min, respec-teins from the pKD46 expression plasmid [43]. Recombinants were
isolated by plating on LB supplemented with 25g/ml chloramphen- tively.
icol, colony purified by passage at nonpermissive temperature
(37C), and then tested for ampicillin sensitivity to achieve the loss Characterization of the TDO Reaction Product by NMR
of the helper plasmid pKD46. Introduction of the desired deletion TDO (290 g) was added to a 0.8 ml solution of L-tryptophan (11.6
was confirmed by PCR and also phenotypically: Cm-resistant re- mM) and ascorbic acid (1 mM) in D2O. After 15 min at room tempera-
combinant colonies were unable to grow on M9 media and growth ture, the NMR spectrum of the reaction mixture demonstrated 100%
could be restored by addition of 50 M niacin. conversion of L-tryptophan to N-formyl-L-kynurenine. 1H NMR
(N-formyl-L-kynurenine), D2O: 3.75 (m, 2H), 4.14 (m, 1H), 7.34 (t, 1H,
J 
 7.8), 7.66 (t, 1H, J 
 7.8), 7.99 (d, 1H, J 
 7.8), 8.15 (d, 1H, J 
In Vivo Verification of the Assembled Tryptophan
7.8), 8.34 (s, 1H).to Quinolinate Pathway
E. coli MG1655:(pnuC-nadA) was transformed with the compatible
plasmids pPRO-rmLocus(RT) and pBAD-chLocus. As a control, this Kinetics Studies on TDO
strain was also transformed with the parent plasmids. These strains For kinetics studies, the activity of TDO was determined by monitor-
were grown in liquid LB media in the presence of the appropriate ing the absorbance increase of the reaction mixture at 321 nm ( 

antibiotics (20 g/ml kanamycin and 20 g/ml ampicillin) to OD600 3152 M1cm1 for N-formyl-L-kynurenine). A typical reaction mixture
0.8. After induction with 0.2% arabinose and 2 mM IPTG, the cells consisted of 0.4 mM L-tryptophan, 0.1 mM l-ascorbate, and the 0.1
were grown for 3 hr, harvested by centrifugation, washed with M9 M TDO in potassium phosphate buffer (0.1 M; pH 7.0) saturated
media, and diluted 1:100 in M9 media supplemented with 0.4% with O2 at room temperature. The reaction was initiated by the addi-
glycerol or glucose, 0.2% arabinose, and 2 mM IPTG in the presence tion of the enzyme.
or absence of 500 M L-tryptophan or 50 M niacin. Cell growth
was monitored by OD600 over 5 days. Alternatively, overnight cultures Overexpression and Purification
washed with M9 media were streaked onto M9 plates supplemented of N-Formylkynurenine Formamidase
with 0.4% glycerol, 0.2% arabinose, and 0.8 mM IPTG in the pres- For characterization of KFA, the expression construct containing
ence or absence of 500 M L-tryptophan or 50 M niacin and grown the KFA gene from Ralstonia metallidurans (with the stop codon at
for 72 hr. position 82 replaced by Tyr) in the pProEX Hta expression vector
was used [38]. The overexpression of this construct was performed
in E. coli BL21(DE3).Overexpression and Purification
E. coli BL21(DE3) transformed with the KFA-containing plasmidof Tryptophan-2,3-Dioxygenase
were grown as described above for TDO. After addition of IPTG,The TDO gene from R. metallidurans was PCR amplified using prim-
the culture was incubated for an additional 15 hr at 27C. The frozeners 5-GGGGATCATGAGCGAATTCAAGGGATGC-3 and 5-GGG
cells were resuspended in 0.1 M potassium phosphate buffer (pHGTCGACTACAGGTCTGTCCGCAGTTTCCACA-3 as the forward
7.4; 15 ml/g cell paste), and the imidazole concentration adjustedand reverse primers, respectively, and plasmid pPRO-rmLocus(RT)
to 10 mM. Ni-NTA chromatography was performed as describedas a template. The PCR fragment was purified, digested with BspHI
above for TDO. KFA eluted from the column was exchanged intoand SalI, cloned into appropriately digested pProEX Hta, and the
0.1 M potassium phosphate (pH 7.4) to remove imidazole and NaCl.resulting DNA used to transform E. coli BL21(DE3). The nucleotide
sequence of the insert was confirmed by DNA sequencing.
LB media (5 ml) containing 100 g/ml of ampicillin was inoculated Characterization of the KFA Reaction Product by HPLC
with a single colony of transformed E. coli BL21(DE3). The culture Analysis and by NMR
was incubated overnight at 37C with agitation. On the next day, 1 A typical reaction mixture contained 30 l of L-tryptophan (10 mM),
liter of LB medium containing 100 g/ml ampicillin was inoculated 25 l of ascorbic acid (2 mM), 10 l of TDO sample (15 M), and
with 100 l of the starter culture. The cells were grown with shaking 435 l of potassium phosphate buffer (0.1 M; pH 7.0). The formation
until the culture reached an A590 of 0.6. IPTG was added to a final of N-formylkynurenine was monitored spectrophotometrically. After
concentration of 0.6 mM, and the culture was incubated for an the L-tryptophan was quantitatively converted to N-formylkynuren-
additional 3 hr at 37C. The cells were then harvested by centrifuga- ine, 10 l of KFA (50 M) was added to the reaction mixture. The
tion at 5000  g for 15 min at 4C and stored at 80C. The frozen enzymatic reaction was stopped after various times by the addition
cells were resuspended in potassium phosphate buffer (0.1 M, pH of 10% v/v trifluoroacetic acid (2 M), and precipitated protein was
7.0, 15 ml/g cell paste). Protease inhibitors (1 mM PMSF, 2 M removed by centrifugation at 9200  g for 2 min. A 50 l sample
leupeptin, and 0.02 mg/ml aprotinin) were added, and the cells were was analyzed by HPLC (reverse-phase LiCrospher RP18, 5 m; flow
sonicated on ice. The cells debris was removed by centrifugation rate, 1ml/min, with mobile phase of 50% MeOH in 0.1 M aqueous
at 20,000  g for 15 min at 4C, and the supernatant containing acetic acid, 0.1 M NH4OAc, pH 4.6). N-formyl-kynurenine and kyn-
TDO was further fractionated by Ni-NTA-affinity chromatography urenine were detected at 321 nm and 360 nm, respectively, and
(Ni-NTA superflow resin). Before application to the Ni-NTA column, eluted after 4.6 and 6 min. For the NMR analysis, the reaction was
the imidazole concentration of the supernatant solution was ad- scaled up 5-fold and the peak eluting after 6 min was collected. 1H
justed to 10 mM. The Ni-NTA column was subsequently washed NMR (L-kynurenine) DMSO d-6: 3.25 (dd, 1H, J 
 18 Hz, J 
 8.78
with 20 ml of 0.05 M potassium phosphate buffer (pH 8.0, 20 mM Hz), 3.52 (dd, 1H, J 
 18.06 Hz, J 
 3.41 Hz), 3.61 (dd, 1H, J 
 8.78
imidazole, 300 mM NaCl). TDO was eluted from the column with Hz, J 
 2.93 Hz), 6.54 (t, 1H, J 
 7.5 Hz), 6.76 (dd, 1H, J 
 8.78 Hz,
0.05 M potassium phosphate, 200 mM imidazole, 300 mM NaCl (pH J 
 0.97 Hz), 7.26 (t, 1H, J 
 7.5 Hz), 7.7 (dd, 1H, J 
 8.3 Hz, J 

8.0). The fractions containing TDO were combined and exchanged 1.46 Hz).
into 0.1 M potassium phosphate (pH 7.0) to remove imidazole and
NaCl from the solution. Kinetics Studies on KFA
For kinetics studies, the activity of KFA was determined by monitor-
ing the absorbance increase of the reaction mixture at 365 nm re-Identification of the TDO Reaction Product by HPLC Analysis
A typical reaction mixture contained 30 l of L-tryptophan (10 mM), sulting from the conversion of N-formyl-L-kynurenine to L-kynuren-
ine (molar extinction coefficients of N-formyl-L-kynurenine and25 l of ascorbic acid (2 mM), 10 l of enzyme sample (10 M), and
435 l of 0.1 M potassium phosphate buffer (pH 7.0). The enzymatic kynurenine at 365 nm are 200 and 4530 M1cm1, respectively).
The reaction mixture contained 100 mM Tris-HCI buffer (pH 7.4), 1 mMreaction was stopped after various times by the addition of 10%
v/v trifluoroacetic acid (2 M), and the precipitated protein was re- N-formyl-L-kynurenine, 20 M ZnCl2, and KFA in a final volume
of 0.5 ml. The reaction was initiated by addition of enzyme aftermoved by centrifugation at 9200  g for 2 min. A 50 l sample was
analyzed by HPLC (reverse-phase LiCrospher RP18, 5m; flow rate, equilibration for 5 min at 37C.
Chemistry & Biology
1202
An alternative assay protocol involved measuring the production 530 l of buffer (0.05 M Tris-acetate, pH 8.0, 1 mM DTT, 0.2 M
mannitol, 0.2% Triton X-100, 5 M FAD), 6 l 10 mM kynurenine,of formate by monitoring the formate dehydrogenase-catalyzed
conversion of NAD to NADH. A typical reaction mixture contained 10 l 12 mM NADPH, 4 l 1.5 M KCl. Reaction was initiated by the
addition of 50 l of enzyme sample (21.6 M). Kinetic parameters100 mM Tris-HCl (pH 7.5), 2 mM NAD, 2 units of formate dehydroge-
nase (Sigma), and an appropriate amount of KFA in 500 l. The were determined by initial-velocity measurements at a fixed concen-
tration of NADPH (0.5 mM) and varying concentrations of kynur-reaction was started by adding N-formylkynurenine (or other formyl-
ated substrate analogs) to 100–200 M and monitored at 340 nm enine.
over a 20 min period.
Overexpression and Purification of 3-Hydroxy-Kynureninase
The KYN gene from R. metallidurans was PCR amplified using 5-Overexpression and Purification
of Kynurenine-3-Monooxygenase GGGGATCATGACAACGCTGACCCGAGC-3 and 5-GGGGTCGAC
TCAGGTCACCGCCGTCCG-3 as the forward and reverse primers,The KMO gene from Cytophaga hutchinsonii was PCR amplified
using 5-TAGTTCGCATATGAAAGAACAGATTACCATTTGCGGCG-3 respectively, and plasmid pPRO-rmLocus(RT) as a template. The
PCR fragment was purified, digested with BspHI and SalI, clonedand 5-CTACTACTCGAGTTATATATATTTTTTTGTCACTGTAATGAC-3
as the forward and reverse primers and C. hutchinsonii genomic into appropriately digested pProEX Hta, and the resulting DNA used
to transform E. coli BL21(DE3). The nucleotide sequence of theDNA as a template. The purified PCR product was digested with
NdeI and XhoI, cloned into the appropriately digested pCR4Blunt insert was confirmed by DNA sequencing.
E. coli BL21(DE3) transformed with the KYN-containing plasmidvector with the Zero Blunt TOPO PCR cloning kit, and the resulting
DNA (pChuKO.28) used to transform E. coli BL21(DE3). The nucleo- was grown as described above for TDO. After addition of IPTG, the
culture was incubated for an additional 10 hr at 30C. Frozen cellstide sequence of the insert was confirmed by DNA sequencing.
E. coli BL21(DE3) transformed with pChuKO.28 were grown as were resuspended in a solution of 1 mM DTT, 0.25 M sucrose, 10
M PLP in 0.1 M Tris-HCl buffer (pH 8.0; 15 ml/g cell paste) fordescribed above for TDO, but in LB media containing 20 g/ml of
kanamycin. After addition of IPTG, the culture was incubated for an sonication. Ni-NTA chromatography was performed as described
above for TDO but with the following buffers. For equilibration, 0.1 Madditional 12 hr at 30C. Frozen cells were resuspended in a solution
of 1 mM DTT, 0.2 M mannitol, 0.2% Triton X-100, and 5 M FAD in Tris-HCl buffer (pH 8.0, 0.25 M sucrose, 10 M PLP, 10 mM imidaz-
ole); for washing, 0.1 M Tris-HCl buffer (pH 8.0, 0.25 M sucrose, 100.05 M Tris-acetate buffer (pH 8.0; 15 ml/g cell paste) for sonication.
Ni-NTA chromatography was performed as described for TDO but M PLP, 0.5 mM DTT, 20 mM imidazole); and for elution, 0.1 M Tris-
HCl buffer (pH 8.0, 0.25 M sucrose, 10 M PLP, 1 mM DTT, 200 mMwith the following buffers. For equilibration, 0.05 M Tris-acetate
buffer (pH 8.0, 0.2 M mannitol, 0.2% Triton X-100, 5 M FAD, 10 imidazole). KYN eluted from the column was exchanged into 0.1 M
Tris-HCl buffer (pH 8.0, 0.25 M sucrose, 7M PLP) to remove imidaz-mM imidazole); for washing, 0.05 M Tris-acetate buffer (pH 8.0,
0.2 M mannitol, 0.2% Triton X-100, 5 M FAD, 0.5 mM DTT, 20 ole from the enzyme-containing solution.
mM imidazole); and for elution, 0.05 M Tris-acetate buffer (0.2 M
mannitol, 0.2% Triton X-100, 5 M FAD, 1 mM DTT, 200 mM imidaz- Identification of the 3-Hydroxy-Kynureninase Reaction
ole, pH 8.0). KMO eluted from the column was exchanged into 0.05 M Product by HPLC and by NMR
Tris-acetate buffer (pH 8.0, 0.2 M mannitol, 0.2% Triton X-100, 5 A typical reaction mixture consisted of 772 l of 100 mM Tris HCl
M FAD) to remove imidazole from the enzyme-containing solution. buffer (pH 8.0), 7 M PLP, 500 M of 3-hydroxykynurenine, and 50
l of KYN (0.21 mg/ml). The reaction was stopped after various
times by the addition of 10% v/v of 2.4 M HClO4. The precipitatedCofactor Identification
The flavin cofactor content was determined by ESI mass spec- protein was removed by centrifugation, and a 50 l sample was
injected into the HPLC column (reverse-phase LiCrospher RP18,trometry.
The flavin cofactor was released by boiling KMO 100 l (21.6 mM) 5 m; flow rate, 1ml/min; solvent A: 0.1 M aqueous acetic acid,
0.1 M NH4Oac, pH 4.65, 2% acetonitrile; solvent B: methanol; gradi-in 200 l of 1 mM ammonium acetate buffer (pH 6.0) for 5 min and
then cooling rapidly on ice. Denatured protein was removed by ent: 100% A to 50% A-50% B over 15 min). The column eluent was
monitored by absorbance at 365 nm (3-hydroxykynurenine) and bycentrifugation at 13,300 g for 5 min. The supernatant was analyzed
by ESI-MS in a positive mode. The flavin cofactor was identified as fluorescence at 410 nm (excitation at 330 nm). 3-hydroxyanthranilic
acid eluted with a retention time of 11 min. The reaction was scaledFAD (m/z 
 786.2; MS/MS analysis m/z 
 438, 348, 250, 136).
KMO can use both NADH and NADPH as cofactors. In the case up 5-fold for NMR analysis. 1H NMR (3-hydroxyanthranilic acid)
DMSO d-6: 6.36 (t, 1H, J 
 7.8), 6.79 (dd, 1H, J 
 1.46, J 
 7.32),of NADH, the specific activity was half that obtained with NADPH.
7.2 (dd, 1H, J 
 1.46, J 
 8.3), 9.6 (s, 1H).
Identification of the KMO Reaction Product by HPLC
and NMR Analysis Kinetic Studies on 3-Hydroxy-Kynureninase
The activity of kynureninase was determined by monitoring the de-A typical reaction mixture contained L-kynurenine (0.1 mM), NADPH
(0.2 mM), and 6 g of KMO in Tris acetate buffer (0.05 M; pH 8.0). crease in absorbance of L-3-hydroxykynurenine at 371nm ( 

3775 M1cm1). A typical assay mixture contained 2.8 l of 1 mMThe enzymatic reaction was stopped after various times by the
addition of 1/10 volume of ice-cold 2.4 M HClO4, and the precipitated PLP in 100 mM Tris-HCl buffer at pH 8, 0.5–20 l of 3-hydroxykyn-
urenine (6.2 mM) or kynurenine (10 mM) in a final reaction volumeprotein was removed by centrifugation at 9200  g for 2 min. A 50
l sample was analyzed by HPLC (reverse-phase LiCrospher RP18, of 0.5 ml. The reaction was initiated by addition of 15 l of the
enzyme (0.2 mg/ml).5 m; flow rate, 1ml/min; solvent A: 0.1 M aqueous acetic acid,
0.1 M NH4Oac, pH 4.65, 2% acetonitrile; solvent B: methanol; gradi-
ent: 100% A to 50% A–50% B over 15 min). The column eluent was Overexpression and Purification
monitored by absorbance at 365 nm. Kynurenine and 3-hydroxy- of 3-Hydroxyanthranilate-3,4-Dioxygenase
kynurenine eluted after 10.3 and 7 min, respectively. The reaction The HAD gene from Cytophaga hutchinsonii was PCR amplified
was scaled up 5-fold, and the HPLC-purified reaction product was using 5-TAGCATATGCTCAAGCCATTTAACTTCAAAGTC-3 and 5-
analyzed by NMR. 1H NMR (3-hydroxy-kynureinine) DMSO d-6: 3.25 GCTACTCGAGTTATCGTTTAACAGGTGC-3 as the forward and re-
(m, 1H, J 
 8.78 Hz), 3.52 (dd, 1H, J 
 18.6, J 
 2.93), 3.61 (dd, 1H, verse primers and pBAD-chLocus as a template. The PCR product
J 
 8.78 Hz, J 
 2.93 Hz), 6.41 (t, 1H, J 
 7.81 Hz), 6.73 (br s, 2H), was purified (with the QIAquick PCR purification kit), digested with
6.83 (d, 1H, J 
 6.83 Hz), 7.20 (d, 2H, J 
 7.81 Hz). NdeI and XhoI, cloned into the appropriately digested pET16b, and
the resulting DNA (pKLC101) used to transform E. coli Tuner(DE3).
The nucleotide sequence of the insert was confirmed by DNA se-Kinetics Studies on Kynurenine-3-Monooxygenase
The activity of kynurenine-3-monooxygenase was determined by quencing. C. hutchinsonii HAD was insoluble upon overexpression;
therefore, the HAD gene from Ralstonia metallidurans was used formonitoring the absorbance decrease of the reaction mixture at 340
nm resulting from the oxidation of NADPH (molar extinction coeffi- biochemical characterization.
The HAD-KYN genes from Ralstonia metallidurans were PCR am-cient of NADPH
 2.7 0.1 mM1). A typical assay mixture contained
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plified using 5-ATGCTGACCTACGGAGCGCCCT-3 and 5-TCAGG signals disappear over time and are replaced by signals that are
characteristic of quinolinate: a doublet of doublets at 7.33 ppm, aTCACTGACTTGCGCGTG-3 as the forward and reverse primers,
respectively. The PCR-amplified fragment was directly cloned into doublet at 7.88 ppm, and a doublet at 8.27 ppm.
pBAD-TOPO with the “TOPO TA” cloning strategy. The E. coli strain
TOP10 was used for subsequent transformation. The resulting plas- Kinetics Studies on 3-Hydroxyanthranilate-3,4-Dioxygenase
mid pBAD-rmLocus was verified by DNA sequence analysis. For kinetic studies, the activity of HAD was monitored over time by
The HAD gene from Ralstonia metallidurans was PCR amplified measuring the absorbance increase at 360 nm resulting from the
using 5-TAGCCATATGCTGACCTACGGAGCGCC-3 and 5-GCT production of -amino--carboxymuconic semialdehyde (360 

AGGATCCTCAGGCCGCGCGTCCGG-3 as the forward and reverse 47,500 M1cm1; [44]). A typical reaction mixture consisted of 4g of
primers and pBAD_1029-28.4 plasmid as a template. The PCR prod- gel-filtered cell-free extract (5% HAD) in 495 l of oxygen-saturated
uct was purified (with the QIAquick PCR purification kit), digested buffer (10 mM phosphate, 20 mM DTT, pH 7.2) and 5 l of a solution
with NdeI and BamHI, cloned into the appropriately digested of 3-hydroxyanthranilate in DMSO (0.05 mM to 6.0 mM).
pET16b, and the resulting DNA (pKLC100) used to transform E. coli
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